News
Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...
5d
Stocktwits on MSNCMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says AnalystsAnalysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...
On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...
5d
Medical Device Network on MSNGeneticure’s test obtains US patent to predict renal denervation responseThe patented method uses genetic markers and a weighted algorithm to assess the responsiveness to renal denervation.
Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...
About the Paradise Ultrasound Renal Denervation System The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN ...
Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...
Discrepant effects of antihypertensive pharmacological treatment ( ) and renal sympathetic denervation ( ) on office and ambulatory BP levels. Regression line with 95% confidence intervals refers to ...
Renal sympathetic nerve activation contributes to the pathogenesis of hypertension. Symplicity HTN-2, a multicenter, randomized trial, demonstrated that catheter-based renal denervation produced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results